Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00875901 · ClinicalTrials.gov registry record · NA
Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT00875901 is a NA study that has completed, run by University of Florida. The registered enrollment target is 23 participants.
The verdict
NCT00875901, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This is a research study to determine if hypofractionated image guided radiation therapy (hypoIGRT) with proton therapy is a good way to treat early stage lung tumors for patients who will not have surgery. HypoIGRT delivers higher daily doses of radiation over a shorter period of time compared with conventional radiation. This is thought to deliver a more lethal dose of radiation to the tumor and is more convenient with treatment being completed within 2-3 weeks compared to the typical 7-8 week course of conventional radiotherapy.
Interventions
- RADIATION Peripherally located lung tumor
- RADIATION Centrally located lung tumor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-09 |
| Est. Completion | 2022-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00875901
The ClinicalTrials.gov registry entry for NCT00875901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peripherally located lung tumor is the first listed.
NCT00875901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00875901 about?
NCT00875901 is a clinical study titled "Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)". This is a research study to determine if hypofractionated image guided radiation therapy (hypoIGRT) with proton therapy is a good way to treat early stage lung tumors for patients who will not have surgery. HypoIGRT delivers higher daily doses of radiation over a shorter period of time compared with...
What is the current status of trial NCT00875901?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2009-09. Estimated completion is 2022-03-21.
What interventions are being tested in trial NCT00875901?
The interventions under investigation include: Peripherally located lung tumor (RADIATION), Centrally located lung tumor (RADIATION).
Who is sponsoring clinical trial NCT00875901?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.